Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H17NO3 |
Molecular Weight | 211.2576 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)C1=CC=C(O)C(O)=C1
InChI
InChIKey=JWZZKOKVBUJMES-UHFFFAOYSA-N
InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3
Molecular Formula | C11H17NO3 |
Molecular Weight | 211.2576 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:27:16 UTC 2023
by
admin
on
Sat Dec 16 16:27:16 UTC 2023
|
Record UNII |
L628TT009W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC01CA02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
NCI_THESAURUS |
C319
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-ATC |
C01CA02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-ATC |
R03AK02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
NDF-RT |
N0000175555
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
NDF-RT |
N0000000245
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-ATC |
R03CB01
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-ATC |
R03AB02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-VATC |
QR03AB02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-VATC |
QR03CB01
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-VATC |
QR03AK02
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-VATC |
QR03CB51
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
||
|
WHO-ATC |
R03CB51
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000087152
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL434
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
D007545
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
1499
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
9975
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
ISOPRENALINE
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
7683-59-2
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
DB01064
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
64317
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
3779
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
m6533
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
L628TT009W
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
6054
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
536
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
SUB08330MIG
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
DTXSID4023175
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
33791
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
m6533
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
231-687-7
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
C62041
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
4201
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY | |||
|
L628TT009W
Created by
admin on Sat Dec 16 16:27:18 UTC 2023 , Edited by admin on Sat Dec 16 16:27:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
TARGET -> AGONIST |
Assay in chinese hamster ovary (CHO) cells stably expressing the three β-adrenergic receptor subtypes at comparable leve50 to 80 pM 125I-CYP were used as radioligand. Experiments were done in the presence of 100 µM GTP.
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST |
SHORT-ACTING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|